WHO ICTRP trial

LOCal Assessment and Triage Evaluation of Non-Alcoholic Fatty Liver Disease…

ACTRN12620000158965 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting

Key facts

Trial ID ACTRN12620000158965
Public title LOCal Assessment and Triage Evaluation of Non-Alcoholic Fatty Liver Disease (LOCATE-NAFLD)
Scientific title LOCal Assessment and Triage Evaluation of Non-Alcoholic Fatty Liver Disease (LOCATE-NAFLD): a randomised trial testing a community fibrosis assessment service for patients with suspected non-alcoholic fatty liver disease
Primary sponsor Queensland University of Technology
Secondary sponsors University of Queensland;University of the Sunshine Coast;Queensland Institute of Medical Research (QIMR Berghofer Medical Reserach Institute)
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Not Recruiting
Study type Interventional
Phase Not Applicable
Countries Australia
Conditions Non-Alcoholic Fatty Liver Disease; Non-Alcoholic Fatty Liver Disease;Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon;Public Health - Health service research
Interventions The starting point for patients is when they visit a GP. If the GP has sufficient concerns about the patient’s liver health, they will write a referral letter requesting a specialist hepatology clinic. The GP may also request blood tests…
Registration date Feb 13, 2020
Target size 156
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations